{"filing":{"accession_number":"0001193125-26-234379","cik":"0001783183","ticker":"PHAT","company_name":"Phathom Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-05-21","report_date":null,"primary_document":"d227860d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1783183/000119312526234379/d227860d8k.htm"},"events":[{"id":9393,"run_id":8237,"accession_number":"0001193125-26-234379","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder voting results from Phathom Pharmaceuticals' 2026 Annual Meeting held on May 19, 2026. The filing presents final voting tallies for three proposals: election of Class I directors (Steven Basta, Theodore R. Schroeder, Mark Stenhouse), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of named executive officer compensation. This is a routine but material Item 5.07 disclosure required by SEC rules.","company_name":"Phathom Pharmaceuticals, Inc.","ticker":"PHAT","filing_date":"2026-05-21","form":"8-K","submitted_at":null,"items":[{"id":1016,"accession_number":"0001193125-26-234379","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Phathom Pharmaceuticals' 2026 Annual Meeting held on May 19, 2026. The filing presents final voting tallies for three proposals: election of Class I directors (Steven Basta, Theodore R. Schroeder, Mark Stenhouse), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of named executive officer compensation. This is a routine but material Item 5.07 disclosure required by SEC rules.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:37:18.394076+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1016,"accession_number":"0001193125-26-234379","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Phathom Pharmaceuticals' 2026 Annual Meeting held on May 19, 2026. The filing presents final voting tallies for three proposals: election of Class I directors (Steven Basta, Theodore R. Schroeder, Mark Stenhouse), ratification of Ernst \u0026 Young LLP as independent auditor, and advisory approval of named executive officer compensation. This is a routine but material Item 5.07 disclosure required by SEC rules.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:37:18.394076+00:00","company_name":"Phathom Pharmaceuticals, Inc.","ticker":"PHAT","filing_date":"2026-05-21"}]}